Payment overview · 2025
General Payments
$15.12
1 reported records · 1 companies
Healthcare provider profile · identity verified
Seth Vensil, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · ZANESVILLE, OH · NPI 1891102489
Verified facts
What the public records show
CMS Open Payments records show Seth Vensil, M.D. received $15.12 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.12 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.12 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $15.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 717 | 210 |
| Levothyroxine Sodium | Levothyroxine Sodium | 440 | 119 |
| Losartan Potassium | Losartan Potassium | 412 | 124 |
| Pantoprazole Sodium | Pantoprazole Sodium | 391 | 122 |
| Lisinopril | Lisinopril | 337 | 107 |
| Amlodipine Besylate | Amlodipine Besylate | 316 | 110 |
| Omeprazole | Omeprazole | 282 | 86 |
| Gabapentin | Gabapentin | 266 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 260 | 80 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 242 | 88 |
| Metformin Hcl | Metformin Hcl | 206 | 58 |
| Furosemide | Furosemide | 204 | 62 |
| Ozempic | Semaglutide | 169 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 162 | 54 |
| Metoprolol Tartrate | Metoprolol Tartrate | 159 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 146 | 61 |
| Potassium Chloride | Potassium Chloride | 143 | 35 |
| Glimepiride | Glimepiride | 137 | 41 |
| Buspirone Hcl | Buspirone Hcl | 134 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 133 | 48 |
| Carvedilol | Carvedilol | 132 | 43 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 132 | 58 |
| Fluticasone Propionate | Fluticasone Propionate | 130 | 64 |
| Diclofenac Sodium | Diclofenac Sodium | 127 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 37 |
| Alendronate Sodium | Alendronate Sodium | 116 | 39 |
| Montelukast Sodium | Montelukast Sodium | 105 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 104 | 27 |
| Meloxicam | Meloxicam | 102 | 34 |
| Eliquis | Apixaban | 95 | 28 |
| Simvastatin | Simvastatin | 93 | 35 |
| Tramadol Hcl | Tramadol Hcl | 93 | 32 |
| Trazodone Hcl | Trazodone Hcl | 90 | 33 |
| Azelastine Hcl | Azelastine Hcl | 89 | 48 |
| Prednisone | Prednisone | 87 | 59 |
| Sertraline Hcl | Sertraline Hcl | 85 | 24 |
| Allopurinol | Allopurinol | 83 | 22 |
| Metformin Hcl Er | Metformin Hcl | 82 | 30 |
| Pregabalin | Pregabalin | 77 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 72 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 66 | 24 |
| Synthroid | Levothyroxine Sodium | 65 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 64 | 18 |
| Bupropion Xl | Bupropion Hcl | 63 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 63 | 23 |
| Famotidine | Famotidine | 62 | 20 |
| Atenolol | Atenolol | 60 | 18 |
| Levofloxacin | Levofloxacin | 60 | 51 |
| Meclizine Hcl | Meclizine Hcl | 60 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 58 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 57 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 55 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 54 | 12 |
| Spironolactone | Spironolactone | 49 | 14 |
| Ondansetron Odt | Ondansetron | 48 | 24 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 11 |
| Finasteride | Finasteride | 46 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 45 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | 15 |
| Jardiance | Empagliflozin | 44 | 15 |
| Trulicity | Dulaglutide | 44 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 43 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 42 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | 13 |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 39 | 12 |
| Ezetimibe | Ezetimibe | 38 | 14 |
| Ibuprofen | Ibuprofen | 38 | 12 |
| Valacyclovir | Valacyclovir Hcl | 38 | 14 |
| Azithromycin | Azithromycin | 37 | 33 |
| Enalapril Maleate | Enalapril Maleate | 36 | suppressed |
| Naproxen | Naproxen | 36 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | 12 |
| Lovastatin | Lovastatin | 33 | suppressed |
| Nystatin | Nystatin | 33 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Loperamide | Loperamide Hcl | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 21 |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Levetiracetam | Levetiracetam | 25 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Glipizide Er | Glipizide | 23 | 13 |
| Methylprednisolone | Methylprednisolone | 23 | 23 |
| Topiramate | Topiramate | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 22 |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 22 |
| Cephalexin | Cephalexin | 21 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 13 |
| Irbesartan | Irbesartan | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Indapamide | Indapamide | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 16 |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | 12 |
| Dulera | Mometasone/Formoterol | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Flunisolide | Flunisolide | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.12 · 1 records | Amgen Inc. | EVENITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error